ProfileGDS4718 / 1569315_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 36% 35% 26% 34% 36% 26% 25% 24% 37% 35% 32% 38% 25% 28% 24% 34% 36% 36% 20% 33% 28% 25% 35% 31% 30% 17% 34% 59% 47% 26% 22% 17% 44% 38% 44% 35% 31% 30% 40% 24% 41% 33% 29% 27% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.8019636
GSM549102patient 115, normal, homogenized [OPG study]4.7738335
GSM549104patient 119, normal, homogenized [OPG study]4.3638826
GSM549108patient 138, normal, homogenized [OPG study]4.7537334
GSM549119patient 077, normal, homogenized [OPG study]4.8093536
GSM549133patient 032, cancer, homogenized [OPG study]4.3283126
GSM549139patient 042, cancer, homogenized [OPG study]4.3129325
GSM549099patient 107, normal, homogenized [OPG study]4.325124
GSM549109patient 139, normal, homogenized [OPG study]4.8843837
GSM549110patient 046, normal, homogenized [OPG study]4.7594435
GSM549114patient 063, normal, homogenized [OPG study]4.5742632
GSM549122patient 082, normal, homogenized [OPG study]4.9266538
GSM549134patient 033, cancer, homogenized [OPG study]4.3266125
GSM549136patient 036, cancer, homogenized [OPG study]4.3960228
GSM549140patient 044, cancer, homogenized [OPG study]4.2587224
GSM549111patient 047, normal, homogenized [OPG study]4.7051934
GSM549113patient 057, normal, homogenized [OPG study]4.7428736
GSM549132patient 031, cancer, homogenized [OPG study]4.7673136
GSM549137patient 038, cancer, homogenized [OPG study]4.1427120
GSM549142patient 047, cancer, homogenized [OPG study]4.766733
GSM549100patient 110, normal, homogenized [OPG study]4.4646128
GSM549107patient 135, normal, homogenized [OPG study]4.3004225
GSM549115patient 068, normal, homogenized [OPG study]4.7024835
GSM549116patient 072, normal, homogenized [OPG study]4.5426231
GSM549120patient 078, normal, homogenized [OPG study]4.5391930
GSM549131patient 030, cancer, homogenized [OPG study]4.0033717
GSM549118patient 074, normal, homogenized [OPG study]4.7109834
GSM549129patient 027, cancer, homogenized [OPG study]6.0663659
GSM549123patient 088, normal, homogenized [OPG study]5.3408847
GSM549124patient 006, cancer, homogenized [OPG study]4.4092526
GSM549126patient 015, cancer, homogenized [OPG study]4.2002822
GSM549128patient 025, cancer, homogenized [OPG study]3.9976817
GSM549103patient 117, normal, homogenized [OPG study]5.2598244
GSM549117patient 073, normal, homogenized [OPG study]4.8439738
GSM549138patient 041, cancer, homogenized [OPG study]5.1961744
GSM549141patient 045, cancer, homogenized [OPG study]4.6734335
GSM549130patient 028, cancer, homogenized [OPG study]4.5990931
GSM549101patient 111, normal, homogenized [OPG study]4.5458930
GSM549105patient 128, normal, homogenized [OPG study]5.0011740
GSM549106patient 134, normal, homogenized [OPG study]4.2581524
GSM549112patient 048, normal, homogenized [OPG study]5.0171441
GSM549125patient 011, cancer, homogenized [OPG study]4.6656233
GSM549127patient 024, cancer, homogenized [OPG study]4.4974829
GSM549135patient 035, cancer, homogenized [OPG study]4.3685527